JPMORGAN CHASE & CO - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 131 filers reported holding INSMED INC in Q3 2018. The put-call ratio across all filers is 2.92 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$10,301,118
+35.2%
407,965
+13.0%
0.00%0.0%
Q2 2023$7,618,324
+52.5%
361,058
+23.3%
0.00%0.0%
Q1 2023$4,995,000
+64004.2%
292,889
-24.9%
0.00%0.0%
Q4 2022$7,792
-99.9%
389,999
+50.9%
0.00%0.0%
Q3 2022$5,568,000
-22.9%
258,524
-29.4%
0.00%0.0%
Q2 2022$7,223,000
+175.1%
366,244
+227.9%
0.00%
Q1 2022$2,626,000
+0.5%
111,702
+16.4%
0.00%
Q4 2021$2,613,000
-52.0%
95,928
-51.5%
0.00%
-100.0%
Q3 2021$5,444,000
-6.4%
197,689
-3.3%
0.00%0.0%
Q2 2021$5,818,000
-2.0%
204,429
+17.3%
0.00%0.0%
Q1 2021$5,934,000
+3.6%
174,213
+1.2%
0.00%0.0%
Q4 2020$5,730,000
+0.4%
172,133
-1.2%
0.00%0.0%
Q3 2020$5,706,000
+13.2%
174,190
-4.8%
0.00%0.0%
Q2 2020$5,039,000
+61.0%
182,977
-6.3%
0.00%0.0%
Q1 2020$3,129,000
-62.0%
195,211
-43.4%
0.00%
-50.0%
Q4 2019$8,234,000
+93.4%
344,797
+42.9%
0.00%
+100.0%
Q3 2019$4,257,000
-63.6%
241,330
-47.8%
0.00%
-50.0%
Q2 2019$11,686,000
+80.0%
461,947
+106.9%
0.00%
+100.0%
Q1 2019$6,492,000
+121.6%
223,312
+0.0%
0.00%0.0%
Q4 2018$2,929,000
-71.4%
223,239
-55.9%
0.00%
-50.0%
Q3 2018$10,240,000
+63.7%
506,391
+91.5%
0.00%
+100.0%
Q2 2018$6,255,000
+26.9%
264,470
+20.9%
0.00%0.0%
Q1 2018$4,928,000
-23.7%
218,794
+5.6%
0.00%0.0%
Q4 2017$6,461,000
-53.1%
207,190
-54.0%
0.00%
-66.7%
Q3 2017$13,782,000
-19.5%
450,401
-54.9%
0.00%
-25.0%
Q2 2017$17,129,000
-33.4%
998,178
-32.1%
0.00%
-33.3%
Q1 2017$25,725,000
+24.2%
1,469,167
-6.1%
0.01%
+20.0%
Q4 2016$20,707,000
-10.8%
1,565,157
-2.1%
0.01%
-16.7%
Q3 2016$23,213,000
+19.2%
1,598,635
-19.0%
0.01%
+20.0%
Q2 2016$19,467,000
-26.3%
1,974,261
-5.3%
0.01%
-28.6%
Q1 2016$26,410,000
-33.4%
2,084,507
-4.5%
0.01%
-30.0%
Q4 2015$39,635,000
+1.7%
2,183,772
+4.1%
0.01%0.0%
Q3 2015$38,959,000
-24.6%
2,097,972
-0.8%
0.01%
-16.7%
Q2 2015$51,659,000
+20.2%
2,115,370
+2.4%
0.01%
+20.0%
Q1 2015$42,969,000
+45.8%
2,065,789
+8.5%
0.01%
+42.9%
Q4 2014$29,467,000
+33.4%
1,904,739
+12.5%
0.01%
+40.0%
Q3 2014$22,091,000
-15.4%
1,692,811
+29.5%
0.01%
-28.6%
Q2 2014$26,113,000
+46.6%
1,306,965
+39.7%
0.01%
+40.0%
Q1 2014$17,818,000
-20.3%
935,801
-28.8%
0.01%
-16.7%
Q4 2013$22,353,000
-8.7%
1,314,839
-16.2%
0.01%
-14.3%
Q3 2013$24,482,000
+513.0%
1,568,318
+369.7%
0.01%
+600.0%
Q2 2013$3,994,000333,9240.00%
Other shareholders
INSMED INC shareholders Q3 2018
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 1,056,797$33,965,00014.39%
Palo Alto Investors LP 6,032,956$193,899,00010.64%
Sycale Advisors (NY) LLC 360,829$11,597,0009.99%
Burrage Capital Management LLC 165,400$5,316,0004.20%
First Light Asset Management, LLC 1,025,341$32,954,0003.38%
Rubric Capital Management LP 1,100,000$35,354,0003.30%
Sofinnova Investments, Inc. 615,143$19,771,0001.47%
Endurant Capital Management LP 144,313$4,638,0001.37%
Parkwood LLC 70,235$5,514,0000.85%
Novo Holdings A/S 430,107$13,824,0000.69%
View complete list of INSMED INC shareholders